Michael E. Hall
Impact in
-
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Heart Failure Treatment and Management 37
- Cardiovascular Function and Risk Factors 35
- Cardiac Fibrosis and Remodeling 27
- Blood Pressure and Hypertension Studies 24
- Physiology 36
- Smoking Behavior and Cessation 26
- Co-authors
- John Edward Hall (31 shared papers)Jussara Marcia do Carmo (10 shared papers)Alexandre A. da Silva (9 shared papers)Zhen Wang (2 shared papers)Merry L. Lindsey (17 shared papers)Yonggang Ma (12 shared papers)Robert Freedman (1 shared paper)Sherry S. Leonard (1 shared paper)
- Journals
- Journal of the American Heart Association (19 papers)Journal of the American College of Cardiology (15 papers)Circulation (8 papers)Nature Communications (8 papers)Peptides (7 papers)
- Partner nations
- United StatesJapanPakistan
In The Last Decade
Michael E. Hall
267 papers receiving 13.3k citations
Michael E. Hall's Hit Papers
Peers
Comparison fields: 5 of 175
- Cardiology and Cardiovascular Medicine 3.8k
- Nephrology 681
- Genetics 1.8k
- Physiology 1.5k
- Cellular and Molecular Neuroscience 758
Countries citing papers authored by Michael E. Hall
This map shows the geographic impact of Michael E. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Hall more than expected).
Fields of papers citing papers by Michael E. Hall
This network shows the impact of papers produced by Michael E. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Hall. The network helps show where Michael E. Hall may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 289 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program Hit paper breakdown → | 2021 | 1363 |
| 2 | Obesity-Induced Hypertension Hit paper breakdown → | 2015 | 992 |
| 3 | 1995 | 607 | |
| 4 | Inherited causes of clonal haematopoiesis in 97,691 whole genomes Hit paper breakdown → | 2020 | 555 |
| 5 | 2013 | 516 | |
| 6 | Obesity, kidney dysfunction and hypertension: mechanistic links Hit paper breakdown → | 2019 | 487 |
| 7 | Obesity, Hypertension, and Cardiac Dysfunction Hit paper breakdown → | 2020 | 445 |
| 8 | Gender differences in perceived stress and coping among college students Hit paper breakdown → | 2021 | 423 |
| 9 | Obesity, hypertension, and chronic kidney disease Hit paper breakdown → | 2014 | 411 |
| 10 | Genetic diversity fuels gene discovery for tobacco and alcohol use Hit paper breakdown → | 2022 | 276 |
| 11 | 2018 | 273 | |
| 12 | Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data Hit paper breakdown → | 2022 | 229 |
| 13 | 2019 | 176 | |
| 14 | Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association Hit paper breakdown → | 2021 | 163 |
| 15 | 1977 | 148 | |
| 16 | 2015 | 143 | |
| 17 | 2014 | 142 | |
| 18 | Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure Hit paper breakdown → | 2023 | 142 |
| 19 | 2015 | 135 | |
| 20 | 2018 | 135 |
About Michael E. Hall
Michael E. Hall is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 289 papers that have together received 13.8k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (37 papers), Cardiovascular Function and Risk Factors (35 papers), Cardiac Fibrosis and Remodeling (27 papers), Smoking Behavior and Cessation (26 papers), Blood Pressure and Hypertension Studies (24 papers), Neuropeptides and Animal Physiology (17 papers), Genetic Associations and Epidemiology (17 papers) and Cardiac Imaging and Diagnostics (12 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.8k citations), Nephrology (681 citations), Genetics (1.8k citations), Physiology (1.5k citations) and Cellular and Molecular Neuroscience (758 citations). Michael E. Hall has collaborated with scholars based in United States, Japan and Pakistan. Frequent co-authors include John Edward Hall, Jussara Marcia do Carmo, Alexandre A. da Silva, Zhen Wang, Merry L. Lindsey, Yonggang Ma, Robert Freedman, Sherry S. Leonard, Lawrence E. Adler and Rugmani Padmanabhan Iyer. Their work appears in journals such as Journal of the American Heart Association, Journal of the American College of Cardiology, Circulation, Nature Communications and Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.